Copyright Reports & Markets. All rights reserved.

Global and United States Single-Use Technologies for the Biologic Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Single-Use Technologies for the Biologic Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Membrane Adsorber
    • 1.2.3 Bioreactors
    • 1.2.4 Disposable Mixing Systems
    • 1.2.5 Tangential Flow Filtration
    • 1.2.6 Tubing and Connectors
    • 1.2.7 Depth Filtration
    • 1.2.8 Buffer Containers
    • 1.2.9 Waste Containers
  • 1.3 Market by Application
    • 1.3.1 Global Single-Use Technologies for the Biologic Market Share by Application: 2020 VS 2026
    • 1.3.2 Monoclonal Antibodies
    • 1.3.3 Vaccines
    • 1.3.4 Gene Therapy
    • 1.3.5 Recombinant Proteins
    • 1.3.6 Blood Derivatives
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Single-Use Technologies for the Biologic Market Perspective (2015-2026)
  • 2.2 Global Single-Use Technologies for the Biologic Growth Trends by Regions
    • 2.2.1 Single-Use Technologies for the Biologic Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Single-Use Technologies for the Biologic Historic Market Share by Regions (2015-2020)
    • 2.2.3 Single-Use Technologies for the Biologic Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Single-Use Technologies for the Biologic Players by Market Size
    • 3.1.1 Global Top Single-Use Technologies for the Biologic Players by Revenue (2015-2020)
    • 3.1.2 Global Single-Use Technologies for the Biologic Revenue Market Share by Players (2015-2020)
  • 3.2 Global Single-Use Technologies for the Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Single-Use Technologies for the Biologic Revenue
  • 3.4 Global Single-Use Technologies for the Biologic Market Concentration Ratio
    • 3.4.1 Global Single-Use Technologies for the Biologic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Single-Use Technologies for the Biologic Revenue in 2019
  • 3.5 Key Players Single-Use Technologies for the Biologic Area Served
  • 3.6 Key Players Single-Use Technologies for the Biologic Product Solution and Service
  • 3.7 Date of Enter into Single-Use Technologies for the Biologic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Single-Use Technologies for the Biologic Breakdown Data by Type (2015-2026)

  • 4.1 Global Single-Use Technologies for the Biologic Historic Market Size by Type (2015-2020)
  • 4.2 Global Single-Use Technologies for the Biologic Forecasted Market Size by Type (2021-2026)

5 Single-Use Technologies for the Biologic Breakdown Data by Application (2015-2026)

  • 5.1 Global Single-Use Technologies for the Biologic Historic Market Size by Application (2015-2020)
  • 5.2 Global Single-Use Technologies for the Biologic Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Single-Use Technologies for the Biologic Market Size (2015-2026)
  • 6.2 North America Single-Use Technologies for the Biologic Market Size by Type (2015-2020)
  • 6.3 North America Single-Use Technologies for the Biologic Market Size by Application (2015-2020)
  • 6.4 North America Single-Use Technologies for the Biologic Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Single-Use Technologies for the Biologic Market Size (2015-2026)
  • 7.2 Europe Single-Use Technologies for the Biologic Market Size by Type (2015-2020)
  • 7.3 Europe Single-Use Technologies for the Biologic Market Size by Application (2015-2020)
  • 7.4 Europe Single-Use Technologies for the Biologic Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Single-Use Technologies for the Biologic Market Size (2015-2026)
  • 8.2 China Single-Use Technologies for the Biologic Market Size by Type (2015-2020)
  • 8.3 China Single-Use Technologies for the Biologic Market Size by Application (2015-2020)
  • 8.4 China Single-Use Technologies for the Biologic Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Single-Use Technologies for the Biologic Market Size (2015-2026)
  • 9.2 Japan Single-Use Technologies for the Biologic Market Size by Type (2015-2020)
  • 9.3 Japan Single-Use Technologies for the Biologic Market Size by Application (2015-2020)
  • 9.4 Japan Single-Use Technologies for the Biologic Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Single-Use Technologies for the Biologic Market Size (2015-2026)
  • 10.2 Southeast Asia Single-Use Technologies for the Biologic Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Single-Use Technologies for the Biologic Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Single-Use Technologies for the Biologic Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific Single-Use Technologies for the Biologic Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in Single-Use Technologies for the Biologic Business (2015-2020))
    • 11.1.5 Thermo Fisher Scientific Recent Development
  • 11.2 Applikon Biotechnology
    • 11.2.1 Applikon Biotechnology Company Details
    • 11.2.2 Applikon Biotechnology Business Overview
    • 11.2.3 Applikon Biotechnology Single-Use Technologies for the Biologic Introduction
    • 11.2.4 Applikon Biotechnology Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.2.5 Applikon Biotechnology Recent Development
  • 11.3 GE Healthcare
    • 11.3.1 GE Healthcare Company Details
    • 11.3.2 GE Healthcare Business Overview
    • 11.3.3 GE Healthcare Single-Use Technologies for the Biologic Introduction
    • 11.3.4 GE Healthcare Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.3.5 GE Healthcare Recent Development
  • 11.4 Pall
    • 11.4.1 Pall Company Details
    • 11.4.2 Pall Business Overview
    • 11.4.3 Pall Single-Use Technologies for the Biologic Introduction
    • 11.4.4 Pall Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.4.5 Pall Recent Development
  • 11.5 BioPure Technology
    • 11.5.1 BioPure Technology Company Details
    • 11.5.2 BioPure Technology Business Overview
    • 11.5.3 BioPure Technology Single-Use Technologies for the Biologic Introduction
    • 11.5.4 BioPure Technology Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.5.5 BioPure Technology Recent Development
  • 11.6 Sartorius
    • 11.6.1 Sartorius Company Details
    • 11.6.2 Sartorius Business Overview
    • 11.6.3 Sartorius Single-Use Technologies for the Biologic Introduction
    • 11.6.4 Sartorius Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.6.5 Sartorius Recent Development
  • 11.7 Novasep
    • 11.7.1 Novasep Company Details
    • 11.7.2 Novasep Business Overview
    • 11.7.3 Novasep Single-Use Technologies for the Biologic Introduction
    • 11.7.4 Novasep Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.7.5 Novasep Recent Development
  • 11.8 W. L. Gore and Associates
    • 11.8.1 W. L. Gore and Associates Company Details
    • 11.8.2 W. L. Gore and Associates Business Overview
    • 11.8.3 W. L. Gore and Associates Single-Use Technologies for the Biologic Introduction
    • 11.8.4 W. L. Gore and Associates Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.8.5 W. L. Gore and Associates Recent Development
  • 11.9 EMD Millipore
    • 11.9.1 EMD Millipore Company Details
    • 11.9.2 EMD Millipore Business Overview
    • 11.9.3 EMD Millipore Single-Use Technologies for the Biologic Introduction
    • 11.9.4 EMD Millipore Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.9.5 EMD Millipore Recent Development
  • 11.10 DowDuPont
    • 11.10.1 DowDuPont Company Details
    • 11.10.2 DowDuPont Business Overview
    • 11.10.3 DowDuPont Single-Use Technologies for the Biologic Introduction
    • 11.10.4 DowDuPont Revenue in Single-Use Technologies for the Biologic Business (2015-2020)
    • 11.10.5 DowDuPont Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Single-Use Technologies for the Biologic Scope and Market Size
    Single-Use Technologies for the Biologic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Single-Use Technologies for the Biologic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Membrane Adsorber
    Bioreactors
    Disposable Mixing Systems
    Tangential Flow Filtration
    Tubing and Connectors
    Depth Filtration
    Buffer Containers
    Waste Containers

    Market segment by Application, split into
    Monoclonal Antibodies
    Vaccines
    Gene Therapy
    Recombinant Proteins
    Blood Derivatives

    Based on regional and country-level analysis, the Single-Use Technologies for the Biologic market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Single-Use Technologies for the Biologic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Thermo Fisher Scientific
    Applikon Biotechnology
    GE Healthcare
    Pall
    BioPure Technology
    Sartorius
    Novasep
    W. L. Gore and Associates
    EMD Millipore
    DowDuPont

    Buy now